Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Fletcher

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Heart, Lung & Circulation|September 1, 2018
Trends in the Incidence of First Acute Myocardial Infarction in Metropolitan and Regional Areas of the Hunter RegionAllan J Davies, Lloyd Butel-Simoes, Crystal Naudin, et al.
Clinical Genitourinary Cancer|August 15, 2022
Natural History of Patients with Prostate MRI Likert 1-3 and Development of RosCaP: a Multivariate Risk Score for Clinically Significant CancerLuca Orecchia, Alessandra Nardi, Peter Fletcher, et al.
Internal Medicine Journal|February 15, 2017
Disparities in the incidence of acute myocardial infarction: long-term trends from the Hunter regionAllan J Davies, Crystal Naudin, Mohammed Al-Omary, et al.
Oncotarget|December 2, 2021
The potential of PIVKA-II as a treatment response biomarker in hepatocellular carcinoma: a prospective United Kingdom cohort studyVandana M Sagar, Kathyrn Herring, Stuart Curbishley, et al.
Internal Medicine Journal|June 26, 2019
Pre-hospital thrombolysis for ST-segment elevation myocardial infarction in regional Australia: long-term follow upArshad A Khan, Trent Williams, Mohamed S Al-Omary, et al.
JAMA Cardiology|May 25, 2022
Management of Acute Coronary Syndromes in Patients in Rural Australia: The MORACS Randomized Clinical TrialFiona Dee, Lindsay Savage, James W Leitch, et al.
NPJ Precision Oncology|March 12, 2025
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancerGary Middleton, Helen L Robbins, Peter Fletcher, et al.
Nature|July 17, 2020
The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.
Nature|September 5, 2020
Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2022
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP StudyJohn Bridgewater, Peter Fletcher, Daniel H Palmer, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Heart, Lung & Circulation|September 1, 2018
Trends in the Incidence of First Acute Myocardial Infarction in Metropolitan and Regional Areas of the Hunter RegionAllan J Davies, Lloyd Butel-Simoes, Crystal Naudin, et al.
Clinical Genitourinary Cancer|August 15, 2022
Natural History of Patients with Prostate MRI Likert 1-3 and Development of RosCaP: a Multivariate Risk Score for Clinically Significant CancerLuca Orecchia, Alessandra Nardi, Peter Fletcher, et al.
Internal Medicine Journal|February 15, 2017
Disparities in the incidence of acute myocardial infarction: long-term trends from the Hunter regionAllan J Davies, Crystal Naudin, Mohammed Al-Omary, et al.
Oncotarget|December 2, 2021
The potential of PIVKA-II as a treatment response biomarker in hepatocellular carcinoma: a prospective United Kingdom cohort studyVandana M Sagar, Kathyrn Herring, Stuart Curbishley, et al.
Internal Medicine Journal|June 26, 2019
Pre-hospital thrombolysis for ST-segment elevation myocardial infarction in regional Australia: long-term follow upArshad A Khan, Trent Williams, Mohamed S Al-Omary, et al.
JAMA Cardiology|May 25, 2022
Management of Acute Coronary Syndromes in Patients in Rural Australia: The MORACS Randomized Clinical TrialFiona Dee, Lindsay Savage, James W Leitch, et al.
NPJ Precision Oncology|March 12, 2025
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancerGary Middleton, Helen L Robbins, Peter Fletcher, et al.
Nature|July 17, 2020
The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.
Nature|September 5, 2020
Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2022
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP StudyJohn Bridgewater, Peter Fletcher, Daniel H Palmer, et al.
Pageof 4